lumasiran 94.5 MG in 0.5 ML Injection

RxCUI: 2467153
RxNorm name: lumasiran 94.5 MG in 0.5 ML Injection
Display name: lumasiran 94.5 MG in 0.5 ML Injection
Full name: lumasiran 94.5 MG in 0.5 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OXLUMO	LUMASIRAN	Alnylam Pharmaceuticals, Inc.	16985a31-f5e4-4557-9266-fc78d4bc5055	2025-12-01	Adverse reactions	Exact identifier rxcui: 2467153

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
16985a31-f5e4-4557-9266-fc78d4bc5055	lumasiran 94.5 MG in 0.5 ML Injection	PSN	9	These highlights do not include all the information needed to use OXLUMO ® safely and effectively. See full prescribing information for OXLUMO. OXLUMO (lumasiran) injection, for subcutaneous use Initial U.S. Approval: 2020	20251201
16985a31-f5e4-4557-9266-fc78d4bc5055	lumasiran 94.5 MG (as lumasiran sodium 100 MG) per 0.5 ML Injection	SY	9	These highlights do not include all the information needed to use OXLUMO ® safely and effectively. See full prescribing information for OXLUMO. OXLUMO (lumasiran) injection, for subcutaneous use Initial U.S. Approval: 2020	20251201
16985a31-f5e4-4557-9266-fc78d4bc5055	lumasiran 94.5 MG per 0.5 ML Injection	SY	9	These highlights do not include all the information needed to use OXLUMO ® safely and effectively. See full prescribing information for OXLUMO. OXLUMO (lumasiran) injection, for subcutaneous use Initial U.S. Approval: 2020	20251201
16985a31-f5e4-4557-9266-fc78d4bc5055	0.5 ML lumasiran 189 MG/ML Injection	SCD	9	These highlights do not include all the information needed to use OXLUMO ® safely and effectively. See full prescribing information for OXLUMO. OXLUMO (lumasiran) injection, for subcutaneous use Initial U.S. Approval: 2020	20251201